June 11 (Reuters) - Britain's medicine regulator approved Novo Nordisk's weight-loss pill on Thursday, making the UK the first market in Europe where patients can access the oral treatment and boos...
LONDON/FRANKFURT, June 10 (Reuters) - Pfizer is reviewing the timing and scope of planned investments in Germany, CEO Albert Bourla said in a letter to Chancellor Friedrich Merz, the latest drugmak...
* Tolerability remains key challenge, with most GLP-1 drugs causing significant side effects
* Equities lose some steam with Nasdaq, S&P 500 red
* Tech stocks rebound on dip buying, led by ASML, Infineon, Nvidia
* AstraZeneca advancing obesity strategy with experimental pill